What will clinical drug development look like in 2050? Expert consensus on AI, wearables, adaptive trials and the future of the CRA role.
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.





































